Research graph
References from PRAGMA-CF versus bronchus–artery pairs to assess the reversibility of bronchiectasis: which one is correct or wrong?. Local targets link to admitted publications; unresolved targets remain external evidence.
Impact of two years of treatment with elexacaftor/tezacaftor/ivacaftor on longitudinal changes in structural lung disease in people with cystic fibrosis: results from the RECOVER trial
10.1093/annalsats/aaoag021 · 2026 · External reference
Fleischner Society: glossary of terms for thoracic imaging
10.1148/radiol.232558 · 2024 · External reference
Quantitative CT evaluation of bronchiectasis improvement in cystic fibrosis after CFTR-modulator therapy
10.1148/ryct.250116 · 2025 · External reference
Reversal of cylindrical bronchial dilatations in a subset of adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor
10.1183/13993003.01794-2023 · 2024 · External reference
Radiographic outcomes in pediatric bronchiectasis and factors associated with reversibility
10.1164/rccm.202402-0411oc · 2024 · External reference
Normative values for lung, bronchial sizes, and bronchus-artery ratios in chest CT scans: from infancy into young adulthood
10.1007/s00330-025-11367-w · 2025 · External reference
